Ghose R R
Br J Clin Pharmacol. 1979;8(Suppl 2):189S-193S.
1 Six previously untreated emergency admissions to hospital with severe hypertension were given oral treatment with labetalol. 2 Pre-treatment diastolic BP exceeded 130 mmHg, and clinical evidence of either accelerated hypertension or encephalopathy was present. 3 Hypotensive response after treatment followed two patterns. 4 Quick-responders (n = 3) showed a sharp fall in BP to normal levels within 2 h, which was subsequently sustained for 10 or more hours. The daily dose of labetalol eventually required to achieve good BP control in this group was relatively low: 600--1200 mg. 5 Slow-responders (n = 3) showed a gradual, less marked fall in BP, which was sustained for many hours. These patients required further doses of labetalol to reduce BP to normal. The eventual daily dose of labetalol that ensured good BP control was high: 1200--2400 mg. 6 Heart rate was little changed by treatment. 7 Complications or side-effects were not observed.
六名此前未经治疗的重度高血压急症入院患者接受了拉贝洛尔口服治疗。
治疗前舒张压超过130 mmHg,且存在加速性高血压或脑病的临床证据。
治疗后的降压反应呈现两种模式。
快速反应者(n = 3)在2小时内血压急剧下降至正常水平,随后维持10小时或更长时间。该组最终实现良好血压控制所需的拉贝洛尔每日剂量相对较低:600 - 1200毫克。
缓慢反应者(n = 3)血压呈逐渐、不太明显的下降,持续数小时。这些患者需要进一步服用拉贝洛尔才能将血压降至正常。确保良好血压控制的拉贝洛尔最终每日剂量较高:1200 - 2400毫克。
治疗后心率变化不大。
未观察到并发症或副作用。